Pearl Health, a pioneering force in democratizing healthcare access through innovative software and services, celebrates CEO and co-founder Michael Kopko’s recognition as an EY Entrepreneur Of The Year® 2024 New York Award winner. Ernst & Young LLP (EY US) bestowed this prestigious accolade upon Kopko in acknowledgment of his transformative leadership and Pearl Health’s impactful…
In a strategic move aimed at fueling regional growth and innovation, Raft Capital Management has unveiled its latest €50 million investment fund. This initiative by the Vilnius-based venture capital firm is set to empower burgeoning businesses across the Baltic States, while also eyeing opportunities in the Nordic countries and Poland. Raft Capital, known for its…
Char.gy, a leader in UK electric vehicle (EV) infrastructure, secures €118.2 million investment to accelerate nationwide expansion of its on-street charging network. The funding, from the Charging Infrastructure Investment Fund (CIIF) managed by Zouk Capital, aims to meet the growing demand for accessible EV charging solutions, particularly for households without off-street parking. Founded in 2016,…
Longeveron Inc, a leading biotechnology company specializing in regenerative medicine, has successfully raised $4.4 million through a warrant exercise transaction aimed at accelerating its innovative cellular therapies. This funding initiative, overseen by H.C. Wainwright & Co. as the exclusive placement agent, marks a pivotal step in Longeveron’s mission to combat rare and chronic aging-related conditions….
Polarean Imaging , a pioneering leader in advanced Magnetic Resonance Imaging (MRI) for pulmonary applications, has successfully concluded a significant $12.6 million financing round through the Alternative Investment Market (AIM) of the London Stock Exchange. The oversubscribed fundraise, co-led by strategic investors NUKEM Isotopes GmbH and Bracco S.p.A., alongside a consortium of new and existing…
NephroDI Therapeutics (NephroDI), a leading near-clinical stage pharmaceutical company specializing in kidney disorders, proudly announces a significant Series A investment from life sciences venture capital firm Sound Bioventures. This latest infusion of capital, in tandem with a previously established strategic corporate partnership, is set to advance the development of NDI-5001, a groundbreaking small molecule AMPK…
Rapafusyn Pharmaceuticals, a trailblazer in the realm of therapeutic drug discovery, has announced a significant milestone with the closure of a Series A financing round, amassing $28 million. This strategic investment round was led by 3E Bioventures Capital and Proxima Ventures Ltd., with participation from Lapam Capital. Rapafusyn is spearheading the development of non-degrading molecular…
VERSES AI Inc proudly announces a transformative strategic investment of US $10 million from Group 42 Holding Ltd (G42), a pioneering UAE-based AI technology group. This partnership marks a pivotal moment for VERSES as it accelerates the development of its next-generation intelligent software systems aimed at revolutionizing cognitive computing. , expressed enthusiasm about the collaboration,…
Brightspeed, a leading fiber broadband provider committed to enhancing connectivity across the nation, has announced a significant boost in its efforts to bridge the digital divide in North Carolina. The company has secured $22.5 million in funding from the N.C. Department of Information Technology’s Division of Broadband and Digital Equity’s Completing Access to Broadband (CAB)…
Hamburg-based DealCircle has marked a pivotal moment in its growth journey with a substantial infusion of capital from Round2 Capital, positioning itself to enhance its pioneering role in technology-driven mergers and acquisitions solutions. Founded in 2018 by entrepreneurs Kai Hesselmann and Graig Gröbli, DealCircle has navigated the competitive landscape of M&A advisory with a distinctive…
